Department III of the Center for Liver Diseases delivers systematic and standardized diagnostic and therapeutic services for patients with acute/chronic hepatitis, liver cirrhosis, hepatocellular carcinoma, hepatic failure, and portal hypertension. The Department has established a comprehensive follow-up management system integrating outpatient services and inpatient care, implementing personalized treatment strategies while emphasizing humanistic care and psychological support for liver disease patients. The Department maintains national leadership in three clinical domains: 

1. Precision treatment and lifelong follow-up management for alcoholic liver disease and dual-diagnosis patients with liver disorders and alcohol use disorder; 

2. A multidisciplinary therapeutic system for refractory critical liver diseases incorporating gut microbiota analysis and fecal microbiota transplantation (FMT) technology; 

3. Comprehensive clinical management of complex cases including hepatic failure, unexplained liver diseases, and rare hepatopathies, with particular expertise in molecular diagnosis-guided therapy for acute-on-chronic liver failure and individualized intervention protocols for portal hypertension.

Through the integration of AI-assisted decision-making systems and evidence-based medical frameworks, it has achieved full-cycle management spanning early screening, precision interventions, and long-term prognosis monitoring.